Heterozygous and generalist MxA super-restrictors overcome breadth-specificity tradeoffs in antiviral restriction

Rechel A. Geiger,Damini Khera,Jeannette L. Tenthorey,Georg Kochs,Laura Graf,Michael Emerman,Harmit S. Malik

DOI: https://doi.org/10.1101/2024.10.10.617484

2024-10-10

Abstract:Antiviral restriction factors such as MxA (myxovirus resistance protein A) inhibit a broad range of viruses. However, they face the challenge of maintaining this breadth as viruses evolve to escape their defense. Viral escape drives restriction factors to evolve rapidly, selecting for amino acid changes at their virus-binding interfaces to regain defense. How do restriction factors balance the breadth of antiviral functions against the need to evolve specificity against individual escaping viruses? We explored this question in human MxA, which uses its rapidly evolving loop L4 as the specificity determinant for such as THOV and IAV. Previous combinatorial mutagenesis of rapidly evolving residues in human MxA loop L4 revealed variants with a ten-fold increase in potency against THOV. However, this strategy did not yield improved IAV restriction, suggesting a strong tradeoff between antiviral specificity and breadth. Here, using a modified combinatorial mutagenesis strategy, we find ‘super-restrictor’ MxA variants with over ten-fold enhanced restriction of the avian IAV strain H5N1 but reduced THOV restriction. Analysis of super-restrictor MxA variants reveals that the identity of residue 561 explains most of MxA’s breadth-specificity tradeoff in H5N1 versus THOV restriction. However, rare ‘generalist’ super-restrictors with enhanced restriction of both viruses allow MxA to overcome the breadth-specificity tradeoff. Finally, we show that a heterozygous combination of two ‘specialist’ super-restrictors, one against THOV and the other against IAV, enhances restriction against both viruses. Thus, two strategies enable restriction factors such as MxA to increase their restriction of diverse viruses to overcome breadth-specificity tradeoffs that may be pervasive in host-virus conflicts.

Microbiology

What problem does this paper attempt to address?

The paper attempts to address the issue of how antiviral restriction factors (such as MxA) evolve specificity against particular escape viruses while maintaining broad-spectrum antiviral functionality. Specifically, the study explores how the MxA protein balances the trade-off between breadth and specificity against different orthomyxoviruses (such as THOV and IAV) through its rapidly evolving L4 loop. By improving combinatorial mutagenesis strategies, researchers identified "super-restrictive" MxA variants and analyzed how these variants overcome the breadth-specificity trade-off. Additionally, some rare "generalist" super-restrictive MxA variants were discovered, which can simultaneously enhance restriction against multiple viruses. Finally, the study also demonstrated that heterozygous combinations of two "specialist" super-restrictive MxA variants can enhance restriction against two viruses, providing new insights into the evolutionary strategies in host-virus conflicts.